Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Animal model is referred as those animals on which biological and pathological experiment are performed and tested. The animal models are used as they have similar physiological and organic structures as that of humans. Moreover, some of the animals have almost similar genetic structures as of humans. So, animal models are used by research scientists and other peoples for studying of certain diseases and treatment of that disease and test the end products before using on the humans and development of new products. Novel drugs are investigated in animals for efficacy and safety before they are examined in peoples.
The Asia Pacific animal model is witnessing tremendous growth during forecast period of 2021 to 2027. The animal model have extensive applications in the area of research and development, production and quality control department. The dynamic factors such as rising investments in vaccines and treatment against contagious diseases is propelling growth of Asia Pacific animal model market. Increasing in demand for therapeutics and vaccines against COVID-19 is also propelling growth of Asia Pacific animal model market. However, high cost of study is hindering growth of Asia Pacific animal model market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the animal model market. In addition, complete analysis of changes on animal model expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The rising incidences of various diseases and viral infections such as COVID-19 increases the demand for animal models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of animal model market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of animal model market during COVID-19 period.
The Asia Pacific animal model market is segmented into animal type, application, end user and country.
The animal type such as pigs, cats, mice, monkey, rabbit and other animal type such as dogs are comprised in the Asia Pacific animal model market. In which pigs are also contributing to the growth of Asia Pacific animal model market. The guinea pig are widely used in medical research. Primarily in the study of respiratory, nervous and immune systems. Gerbils and guinea pig have a similar hearing range as of humans which makes them more demandable in the market.
The applications such as research and development and production and quality control are covered in the Asia Pacific animal model market. The production and quality control is also contributing in the growth of Asia Pacific animal model market. The growing research and development activities is propelling growth of Asia Pacific animal model market. The rising production of new medicines is also boosting growth of Asia Pacific animal model market.
The end users like research institutes, pharmaceutical companies, contract research organizations and educational institutes are comprised in the Asia Pacific animal model market. In which educational institutes are also contributing to the growth of Asia Pacific animal model market. The rising use of animal for biological evaluations is propelling growth of Asia Pacific animal model market. The growing development of new entities is also boosting growth of Asia Pacific animal model market.
The Asia Pacific animal model market is studied for key countries such as China, India, Japan, Australia and South Korea. The China followed by India and Japan are anticipated to dominate the market in 2020. The growing prevalence of chronic diseases is propelling growth of Asia Pacific animal model market. The growing research and development activities is also boosting growth of Asia Pacific animal model market. The rising product launch and development of novel therapies is also driving growth of Asia Pacific animal model market.
The key players comprised in animal model market are Janvier Labs, Charles River Laboratories, Genoway S.A., Envigo, Taconic Laboratories, Transgenic Inc., Sage Labs, Horizon Discovery, Crown Bioscience Inc. and Harbor Antibodies Bv (A Subsidiary Of Harbor Biomed) among others.
Apr 2021: Horizon Discovery is shared that IGM Biosciences, a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies has signed a multi-license commercial agreement within two years of their first license for the continued use of the Horizons cGMP-compliant CHO SOURCE platform for further development of IGM’s novel therapeutic IgM antibodies.
January 2020: Horizon Discovery Group plc (Horizon or the Group), a global leader in the application of gene editing and gene modulation technologies, has announced the collaboration and license agreement with Mammoth Biosciences (Mammoth or the Company), for access of Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics such as therapeutic antibodies.
December 2019: Horizon Discovery Group plc (Horizon), a global leader in the application of gene editing and gene modulation for cell line engineering, announced their partnership with The Human Protein Atlas (HPA). HPA has selected Horizon’s CRISPR-edited knockout cell models to further expand the knowledge available in its Cell Atlas program, to advance our understanding of the genetic drivers of disease.
September 2019: Horizon Discovery Group plc (Horizon), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the full commercial licensing to Glen Mark Pharmaceuticals, a global innovative pharmaceutical company, for its gene-edited Glutamine Synthetizes (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line. Terms of the agreement were based on stringent evaluation of the cell line by Glen mark to assess its suitability for adoption into the Company’s biomanufacturing processes.
March 2019: Horizon Discovery Group plc (Horizon), a global leader in gene editing and gene modulation technologies, announced their collaboration with St George’s University Hospital, London, and the European Molecular Genetics Quality Network (EMQN), based within the Manchester Centre for Genomic Medicine at Saint Mary’s Hospital, to develop reference material for non-invasive prenatal testing (NIPT).
The report analyses the animal model market based on animal type, application, end user and country. The various types of animals covered in the report are pigs, cats, mice, monkey, rabbit and other animal such as dog. By application, the market is segmented into research and development and production and quality control. Based on end user, the market is segmented into research institutes, pharmaceutical companies, contract research organizations and educational institutes. The report also covered the impact of COVID-19 on the animal model market and it is found that the rising incidences of various diseases and viral infections such as COVID-19 increases the demand for animal models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of animal model market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of animal model market during COVID-19 period. The report also covers the major key players operating in the market.
Why to buy this report
